Effect and cardiovascular safety of adding rosiglitazone to insulin therapy in type 2 diabetes: A meta-analysis

about

Current Advances in the Biochemical and Physiological Aspects of the Treatment of Type 2 Diabetes Mellitus with Thiazolidinediones The current role of thiazolidinediones in diabetes management.

P2860

Q26745533-79FBE88C-14DC-462E-AC2F-9CB37AA1D0A1 Q30250347-E5E8D50C-A77E-4588-9209-07DEDBE5FB67

P2860

Effect and cardiovascular safety of adding rosiglitazone to insulin therapy in type 2 diabetes: A meta-analysis

Item

http://www.wikidata.org/entity/Q42003332

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Effect and cardiovascular safe ...... pe 2 diabetes: A meta-analysis

@en

Effect and cardiovascular safe ...... pe 2 diabetes: A meta-analysis

@nl

type

Item

label

Effect and cardiovascular safe ...... pe 2 diabetes: A meta-analysis

@en

Effect and cardiovascular safe ...... pe 2 diabetes: A meta-analysis

@nl

prefLabel

Effect and cardiovascular safe ...... pe 2 diabetes: A meta-analysis

@en

Effect and cardiovascular safe ...... pe 2 diabetes: A meta-analysis

@nl

P1476

Effect and cardiovascular safe ...... pe 2 diabetes: A meta-analysis

@en

P2093

Delin Ma

http://www.w3.org/2001/XMLSchema#string

Shiying Shao

http://www.w3.org/2001/XMLSchema#string

Weijie Xu

http://www.w3.org/2001/XMLSchema#string

Xuefeng Yu

http://www.w3.org/2001/XMLSchema#string

Yu Lu

http://www.w3.org/2001/XMLSchema#string

P2860

Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline From the American College of Physicians

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitus

Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies

The case of the misleading funnel plot

Measuring inconsistency in meta-analyses

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.

Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone.

P304

78-86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JDI.12246

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264769095

http://www.w3.org/2001/XMLSchema#string

P698

25621136

http://www.w3.org/2001/XMLSchema#string

P932

4296706

http://www.w3.org/2001/XMLSchema#string

Effect and cardiovascular safety of adding rosiglitazone to insulin therapy in type 2 diabetes: A meta-analysis

about

P2860

P2860

Effect and cardiovascular safety of adding rosiglitazone to insulin therapy in type 2 diabetes: A meta-analysis

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932